Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPRECIATE: Sarilumab Effects on Bone Erosions in Rheumatoid Arthritis
jRCTs031210665Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- May 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of sarilumab in rheumatoid arthritis (RA), sponsored by Asahi Kasei Corporation. Started May 2022; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCTs031210665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210665.